Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by knowsbeston Feb 18, 2021 9:53am
260 Views
Post# 32594549

G Copeland and more misleading information

G Copeland and more misleading information

Dr. Glenn Copeland, the director of medical services for the Ottawa Redblacks and a team doctor with the Blue Jays, and Toronto’s QuestCap have formed a team that includes Dr. Lawrence Steinman, a professor of neurology at Stanford University, and the data encryption company Yoti in the United Kingdom.

Their plan is to be able to process athletes and team staff through an “inner circle” — one based on temperature checks and serology tests — to ensure teams are COVID-19 free before playing their respective sports.

 

Copeland says teams from all four major professional sports in North America have approached QuestCap for more information about the company’s return-to-sports model and its exclusive North and South American rights to serology test kits from Korean manufacturer PCL.

“I’ve been approached in the last two weeks by upwards of 20 teams,” Copeland said. “They want to educate themselves about what can be done and what they can do. It’s been an incredible spirit of co-operation.”  
They only have Huston Rockets .He could be the next target for facts finding mission . Some reviews to come in due time. 

 

<< Previous
Bullboard Posts
Next >>